214 related articles for article (PubMed ID: 18809601)
1. Missing patient-reported outcome data in an adjuvant lung cancer study.
Land SR
J Clin Oncol; 2008 Nov; 26(31):5018-9. PubMed ID: 18809601
[No Abstract] [Full Text] [Related]
2. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA
J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers].
Le Chevalier T
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932
[No Abstract] [Full Text] [Related]
4. Early-stage lung cancer findings end a debate, put focus on next steps.
McNeil C
J Natl Cancer Inst; 2004 Jul; 96(14):1054-5. PubMed ID: 15265961
[No Abstract] [Full Text] [Related]
5. [A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer].
Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):195-6. PubMed ID: 11355584
[No Abstract] [Full Text] [Related]
6. [Adjuvant chemotherapy for non-small cell lung cancer].
Okamoto T; Ichinose Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):1985-90. PubMed ID: 17197740
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
8. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Mornex F
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
[No Abstract] [Full Text] [Related]
9. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Okamoto T; Ichinose Y
Gan To Kagaku Ryoho; 2005 Jun; 32(6):765-9. PubMed ID: 15984513
[TBL] [Abstract][Full Text] [Related]
11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
12. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
Alam N; Shepherd FA; Winton T; Graham B; Johnson D; Livingston R; Rigas J; Whitehead M; Ding K; Seymour L
Lung Cancer; 2005 Mar; 47(3):385-94. PubMed ID: 15713522
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
Besse B; Le Chevalier T
J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
[No Abstract] [Full Text] [Related]
14. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis.
Pignon JP; Stewart LA
Cancer; 1996 Jun; 77(11):2413-4. PubMed ID: 8635115
[No Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy for lung cancer.
Ikhlaque N; Baumann MA
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703
[No Abstract] [Full Text] [Related]
16. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
Ramsden K; Laskin J; Ho C
Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
[TBL] [Abstract][Full Text] [Related]
17. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
Belani CP
Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
[No Abstract] [Full Text] [Related]
18. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
19. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for lung cancer.
Büyükçelik A; Utkan G; Yalçin B
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
